These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 25776438)

  • 81. HIV-associated anal squamous cell cancer: an otherwise preventable disease.
    Konstantinopoulos PA; Schlecht HP; Bryan B; Pantanowitz L; Dezube BJ
    J Clin Oncol; 2006 Sep; 24(27):4516-7. PubMed ID: 16983122
    [No Abstract]   [Full Text] [Related]  

  • 82. Chemoradiotherapy with and without deep regional hyperthermia for squamous cell carcinoma of the anus.
    Ott OJ; Schmidt M; Semrau S; Strnad V; Matzel KE; Schneider I; Raptis D; Uter W; Grützmann R; Fietkau R
    Strahlenther Onkol; 2019 Jul; 195(7):607-614. PubMed ID: 30390114
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Treatment of carcinoma of the anal canal at Groote Schuur Hospital.
    Robertson B; Shepherd L; Abratt RP; Hunter A; Goldberg P
    S Afr Med J; 2012 May; 102(6):559-61. PubMed ID: 22668963
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A population-based analysis of the impact of 1 vs. 2 doses of mitomycin on patterns of failure of anal cancer patients treated with concurrent chemoradiotherapy.
    Joseph K; Al Habsi Z; Abraham A; Elangovan A; Ghosh S; Pham T; Shreekumar D; Ramji Z; Paulson K; Tankel K; Usmani N; Severin D; Schiller D; Wong C; Mulder K; Karachiwala H; Doll C; King K; Nijjar T
    Radiother Oncol; 2024 Jul; 196():110219. PubMed ID: 38479443
    [TBL] [Abstract][Full Text] [Related]  

  • 85. VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02).
    Feliu J; Garcia-Carbonero R; Capdevila J; Guasch I; Alonso-Orduna V; Lopez C; Garcia-Alfonso P; Castanon C; Sevilla I; Cerezo L; Conill C; Quintana-Angel B; Sanchez ME; Ghanem I; Martin-Richard M; Lopez-Gomez M; Leon A; Caro M; Fernandez T; Maurel J
    Cancer Med; 2020 Feb; 9(3):1008-1016. PubMed ID: 31851776
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Evolution and Management of Treatment-Related Toxicity in Anal Cancer.
    Ludmir EB; Kachnic LA; Czito BG
    Surg Oncol Clin N Am; 2017 Jan; 26(1):91-113. PubMed ID: 27889040
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Capecitabine With Mitomycin Reduces Acute Hematologic Toxicity and Treatment Delays in Patients Undergoing Definitive Chemoradiation Using Intensity Modulated Radiation Therapy for Anal Cancer.
    Goodman KA; Julie D; Cercek A; Cambridge L; Woo KM; Zhang Z; Wu AJ; Reidy DL; Segal NH; Stadler ZK; Saltz LB
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1087-1095. PubMed ID: 28721892
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Anal cancer treatment: current status and future perspectives.
    Ghosn M; Kourie HR; Abdayem P; Antoun J; Nasr D
    World J Gastroenterol; 2015 Feb; 21(8):2294-302. PubMed ID: 25741135
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Evaluation of a 36 Gy elective node irradiation dose in anal cancer.
    Lépinoy A; Lescut N; Puyraveau M; Caubet M; Boustani J; Lakkis Z; Fantoli M; Buffet-Miny J; Kim S; Bednarek C; Maingon P; Créhange G; Bosset JF
    Radiother Oncol; 2015 Aug; 116(2):197-201. PubMed ID: 26277433
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment of anal carcinoma in the elderly: feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy.
    Allal AS; Obradovic M; Laurencet F; Roth AD; Spada A; Marti MC; Kurtz JM
    Cancer; 1999 Jan; 85(1):26-31. PubMed ID: 9921970
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus-Reducing the Colostomy Rate.
    Kent C; Bessell EM; Scholefield JH; Chappell S; Marsh L; Mills J; Sayers I
    J Gastrointest Cancer; 2017 Mar; 48(1):1-7. PubMed ID: 27412395
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Long-term follow-up of a Phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with anal cancer (ECOG E4292).
    Chakravarthy AB; Catalano PJ; Martenson JA; Mondschein JK; Wagner H; Mansour EG; Talamonti MS; Benson AB
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e607-13. PubMed ID: 21514072
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Treatment of relapsing anal carcinoma.
    Tanum G
    Acta Oncol; 1993; 32(1):33-5. PubMed ID: 8466762
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
    Leon O; Hagberg O; Johnsson A
    Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Organ-preserving multimodality management of squamous cell carcinoma of anal canal.
    Deo SV; Shukla NK; Raina V; Mohanti BK; Sharan R; Kar M; Rath GK
    Indian J Gastroenterol; 2005; 24(5):201-4. PubMed ID: 16361764
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A clinical trial with protracted infusion 5-fluorouracil and mitomycin C for localized squamous cell carcinoma of the anus.
    Ngan D; Chu J; Chander S; Michael M; Heriot AG; Ngan SY; Rischin D; Leong T
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):75-81. PubMed ID: 30536770
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Effectiveness of chemoradiotherapy for three cases of squamous cell anal carcinoma].
    Takeno A; Mishima H; Ikenaga M; Masuda N; Kashiwazaki M; Takeda Y; Hirao M; Fujitani K; Sawamura T; Tsujinaka T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1870-2. PubMed ID: 15553743
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan.
    Takahashi R; Osumi H; Wakatsuki T; Yamamoto N; Taguchi S; Nakayama I; Ooki A; Ogura M; Takahari D; Chin K; Yamaguchi K; Shinozaki E
    Int J Clin Oncol; 2024 Aug; 29(8):1161-1172. PubMed ID: 38819609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.